Market Research Logo

Rheumatoid Arthritis - Pipeline Review, H1 2015

Rheumatoid Arthritis - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Rheumatoid Arthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rheumatoid Arthritis and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Rheumatoid Arthritis
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Rheumatoid Arthritis and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Rheumatoid Arthritis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Rheumatoid Arthritis pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Rheumatoid Arthritis
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Rheumatoid Arthritis pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Rheumatoid Arthritis Overview
Therapeutics Development
Rheumatoid Arthritis - Therapeutics under Development by Companies
Rheumatoid Arthritis - Therapeutics under Investigation by Universities/Institutes
Rheumatoid Arthritis - Pipeline Products Glance
Rheumatoid Arthritis - Products under Development by Companies
Rheumatoid Arthritis - Products under Investigation by Universities/Institutes
Rheumatoid Arthritis - Companies Involved in Therapeutics Development
Rheumatoid Arthritis - Therapeutics Assessment
Drug Profiles
Rheumatoid Arthritis - Recent Pipeline Updates
Rheumatoid Arthritis - Dormant Projects
Rheumatoid Arthritis - Discontinued Products
Rheumatoid Arthritis - Product Development Milestones
Appendix
List of Tables
Number of Products under Development for Rheumatoid Arthritis, H1 2015
Number of Products under Development for Rheumatoid Arthritis - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Development by Companies, H1 2015 (Contd..3)
Number of Products under Development by Companies, H1 2015 (Contd..4)
Number of Products under Development by Companies, H1 2015 (Contd..5)
Number of Products under Development by Companies, H1 2015 (Contd..6)
Number of Products under Development by Companies, H1 2015 (Contd..7)
Number of Products under Development by Companies, H1 2015 (Contd..8)
Number of Products under Development by Companies, H1 2015 (Contd..9)
Number of Products under Development by Companies, H1 2015 (Contd..10)
Number of Products under Development by Companies, H1 2015 (Contd..11)
Number of Products under Development by Companies, H1 2015 (Contd..12)
Number of Products under Development by Companies, H1 2015 (Contd..13)
Number of Products under Development by Companies, H1 2015 (Contd..14)
Number of Products under Development by Companies, H1 2015 (Contd..15)
Number of Products under Development by Companies, H1 2015 (Contd..16)
Number of Products under Development by Companies, H1 2015 (Contd..17)
Number of Products under Development by Companies, H1 2015 (Contd..18)
Number of Products under Investigation by Universities/Institutes, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..2)
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Development by Companies, H1 2015 (Contd..4)
Products under Development by Companies, H1 2015 (Contd..5)
Products under Development by Companies, H1 2015 (Contd..6)
Products under Development by Companies, H1 2015 (Contd..7)
Products under Development by Companies, H1 2015 (Contd..8)
Products under Development by Companies, H1 2015 (Contd..9)
Products under Development by Companies, H1 2015 (Contd..10)
Products under Development by Companies, H1 2015 (Contd..11)
Products under Development by Companies, H1 2015 (Contd..12)
Products under Development by Companies, H1 2015 (Contd..13)
Products under Development by Companies, H1 2015 (Contd..14)
Products under Development by Companies, H1 2015 (Contd..15)
Products under Development by Companies, H1 2015 (Contd..16)
Products under Development by Companies, H1 2015 (Contd..17)
Products under Development by Companies, H1 2015 (Contd..18)
Products under Development by Companies, H1 2015 (Contd..19)
Products under Development by Companies, H1 2015 (Contd..20)
Products under Development by Companies, H1 2015 (Contd..21)
Products under Development by Companies, H1 2015 (Contd..22)
Products under Development by Companies, H1 2015 (Contd..23)
Products under Development by Companies, H1 2015 (Contd..24)
Products under Development by Companies, H1 2015 (Contd..25)
Products under Development by Companies, H1 2015 (Contd..26)
Products under Development by Companies, H1 2015 (Contd..27)
Products under Investigation by Universities/Institutes, H1 2015
Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..2)
Rheumatoid Arthritis - Pipeline by 3SBio Inc., H1 2015
Rheumatoid Arthritis - Pipeline by 4SC AG, H1 2015
Rheumatoid Arthritis - Pipeline by AB Science, H1 2015
Rheumatoid Arthritis - Pipeline by AB2 Bio Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by AbbVie Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Ablynx NV, H1 2015
Rheumatoid Arthritis - Pipeline by Acceleron Pharma, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Addex Therapeutics Ltd, H1 2015
Rheumatoid Arthritis - Pipeline by Advinus Therapeutics Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Aegera Therapeutics Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Alder Biopharmaceuticals Inc., H1 2015
Rheumatoid Arthritis - Pipeline by AlphaMab Co., Ltd, H1 2015
Rheumatoid Arthritis - Pipeline by Amgen Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Amura Holdings Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Aprogen, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Araim Pharmaceuticals Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Arena Pharmaceuticals, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by arGentis Pharmaceuticals, LLC, H1 2015
Rheumatoid Arthritis - Pipeline by Arrien Pharmaceuticals, LLC, H1 2015
Rheumatoid Arthritis - Pipeline by Arthrogen BV, H1 2015
Rheumatoid Arthritis - Pipeline by Asahi Kasei Pharma Corp., H1 2015
Rheumatoid Arthritis - Pipeline by Aslan Pharmaceuticals Pte. Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Astellas Pharma Inc., H1 2015
Rheumatoid Arthritis - Pipeline by AstraZeneca Plc, H1 2015
Rheumatoid Arthritis - Pipeline by AuraSense Therapeutics, LLC, H1 2015
Rheumatoid Arthritis - Pipeline by Avesthagen Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Avexxin AS, H1 2015
Rheumatoid Arthritis - Pipeline by Axxam SpA, H1 2015
Rheumatoid Arthritis - Pipeline by Baliopharm AG, H1 2015
Rheumatoid Arthritis - Pipeline by Bio-Cancer Treatment International Limited, H1 2015
Rheumatoid Arthritis - Pipeline by BIOCAD, H1 2015
Rheumatoid Arthritis - Pipeline by Biocon Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Bioheart, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Biokine Therapeutics Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by BioMarin Pharmaceutical Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Bionomics Limited, H1 2015
Rheumatoid Arthritis - Pipeline by BioTherapeutics Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Biotie Therapies Corp., H1 2015
Rheumatoid Arthritis - Pipeline by Boehringer Ingelheim GmbH, H1 2015
Rheumatoid Arthritis - Pipeline by Bone Medical Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Boryung Pharmaceutical Co., Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Bristol-Myers Squibb Company, H1 2015
Rheumatoid Arthritis - Pipeline by Can-Fite BioPharma Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Cardax Pharmaceuticals, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by CASI Pharmaceuticals Inc., H1 2015
Rheumatoid Arthritis - Pipeline by CEL-SCI Corporation, H1 2015
Rheumatoid Arthritis - Pipeline by Celgene Corporation, H1 2015
Rheumatoid Arthritis - Pipeline by Cellceutix Corporation, H1 2015
Rheumatoid Arthritis - Pipeline by Celltrion, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Cellworks Group, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by ChemoCentryx, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Chipscreen Biosciences Ltd, H1 2015
Rheumatoid Arthritis - Pipeline by ChironWells GmbH, H1 2015
Rheumatoid Arthritis - Pipeline by Chong Kun Dang Pharmaceutical Corp., H1 2015
Rheumatoid Arthritis - Pipeline by Chugai Pharmaceutical Co., Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by CLL Pharma, H1 2015
Rheumatoid Arthritis - Pipeline by Coherus BioSciences, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Compugen Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Creabilis SA, H1 2015
Rheumatoid Arthritis - Pipeline by CrystalGenomics, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Cyclacel Pharmaceuticals, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Daiichi Sankyo Company, Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Dong-A Socio Group, H1 2015
Rheumatoid Arthritis - Pipeline by Effimune SAS, H1 2015
Rheumatoid Arthritis - Pipeline by Eisai Co., Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Eli Lilly and Company, H1 2015
Rheumatoid Arthritis - Pipeline by Emergent BioSolutions Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Enceladus Pharmaceuticals BV, H1 2015
Rheumatoid Arthritis - Pipeline by Endocyte, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Ensemble Therapeutics Corporation, H1 2015
Rheumatoid Arthritis - Pipeline by Epirus Biopharmaceuticals, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by F. Hoffmann-La Roche Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Farmacija d.o.o. Tuzla, H1 2015
Rheumatoid Arthritis - Pipeline by Five Prime Therapeutics, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Fountain Biopharma Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Galapagos NV, H1 2015
Rheumatoid Arthritis - Pipeline by GeneFrontier Corporation, H1 2015
Rheumatoid Arthritis - Pipeline by Genentech, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Genor BioPharma Co., Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Genosco, H1 2015
Rheumatoid Arthritis - Pipeline by Gilead Sciences, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by GlaxoSmithKline Plc, H1 2015
Rheumatoid Arthritis - Pipeline by Griffin Discoveries BV, H1 2015
Rheumatoid Arthritis - Pipeline by Handok Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Hanwha Chemical Corporation, H1 2015
Rheumatoid Arthritis - Pipeline by Hospira, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Huabo Biopharm Co., Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Hutchison MediPharma Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Idera Pharmaceuticals, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by IMMD Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Immune Response BioPharma, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by ImmunoFrontier, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Inbiopro Solutions Pvt. Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Innate Pharma SA, H1 2015
Rheumatoid Arthritis - Pipeline by Innovent Biologics, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Invion Limited, H1 2015
Rheumatoid Arthritis - Pipeline by InvivoGen Therapeutics, H1 2015
Rheumatoid Arthritis - Pipeline by Jiangsu Hengrui Medicine Co., Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Johnson & Johnson, H1 2015
Rheumatoid Arthritis - Pipeline by Kadmon Corporation, LLC, H1 2015
Rheumatoid Arthritis - Pipeline by KAHR medical Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Kineta, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Lead Pharma Holding B.V., H1 2015
Rheumatoid Arthritis - Pipeline by LG Life Sciences, Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Lupin Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Lycera Corp., H1 2015
Rheumatoid Arthritis - Pipeline by Mabion SA, H1 2015
Rheumatoid Arthritis - Pipeline by MacroGenics, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by MaimoniDex RA Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Mebiopharm Co., Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by MedAnnex Ltd, H1 2015
Rheumatoid Arthritis - Pipeline by MediGene AG, H1 2015
Rheumatoid Arthritis - Pipeline by MedImmune, LLC, H1 2015
Rheumatoid Arthritis - Pipeline by Merck & Co., Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Mertiva AB, H1 2015
Rheumatoid Arthritis - Pipeline by Mesoblast Limited, H1 2015
Rheumatoid Arthritis - Pipeline by MetrioPharm AG, H1 2015
Rheumatoid Arthritis - Pipeline by Mitsubishi Tanabe Pharma Corporation, H1 2015
Rheumatoid Arthritis - Pipeline by Modern Biosciences Plc, H1 2015
Rheumatoid Arthritis - Pipeline by ModiQuest B.V., H1 2015
Rheumatoid Arthritis - Pipeline by Momenta Pharmaceuticals, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Morphotek, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Mycenax Biotech Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Myos Corporation, H1 2015
Rheumatoid Arthritis - Pipeline by Myungmoon pharmaceutical Co.,Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Navigen Pharmaceuticals, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Neovacs SA, H1 2015
Rheumatoid Arthritis - Pipeline by Nichi-Iko Pharmaceutical Co., Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Nimbus Therapeutics, LLC, H1 2015
Rheumatoid Arthritis - Pipeline by Novartis AG, H1 2015
Rheumatoid Arthritis - Pipeline by NovImmune SA, H1 2015
Rheumatoid Arthritis - Pipeline by Nuvo Research Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Omeros Corporation, H1 2015
Rheumatoid Arthritis - Pipeline by Oncobiologics, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by OncoImmune, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Ono Pharmaceutical Co., Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Onyx Pharmaceuticals, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by OPKO Health, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Opsona Therapeutics Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Orchid Chemicals & Pharmaceuticals Ltd, H1 2015
Rheumatoid Arthritis - Pipeline by Oscotec Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Padlock Therapeutics, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Panacea Biotec Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Paras Biopharmaceuticals Finland Oy, H1 2015
Rheumatoid Arthritis - Pipeline by Peptinnovate Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Peptinov SAS, H1 2015
Rheumatoid Arthritis - Pipeline by Pfenex Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Pfizer Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Pharmacyclics, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by PharmaIN Corporation, H1 2015
Rheumatoid Arthritis - Pipeline by Pharmedartis GmbH, H1 2015
Rheumatoid Arthritis - Pipeline by Phenex Pharmaceuticals AG, H1 2015
Rheumatoid Arthritis - Pipeline by Philogen S.p.A., H1 2015
Rheumatoid Arthritis - Pipeline by Phylogica Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Principia Biopharma Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Progenra, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by ProNoxis AB, H1 2015
Rheumatoid Arthritis - Pipeline by ProtAb Ltd, H1 2015
Rheumatoid Arthritis - Pipeline by Protalex, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Protalix BioTherapeutics, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Provid Pharmaceuticals, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by PurGenesis Technologies Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Qu Biologics Inc., H1 2015
Rheumatoid Arthritis - Pipeline by R-Pharm, H1 2015
Rheumatoid Arthritis - Pipeline by Re-Pharm Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Reata Pharmaceuticals, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Recoly N.V., H1 2015
Rheumatoid Arthritis - Pipeline by RedHill Biopharma Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Redx Pharma Plc, H1 2015
Rheumatoid Arthritis - Pipeline by Regeneron Pharmaceuticals, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Reliance Life Sciences Pvt. Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by ReveraGen BioPharma, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Rhizen Pharmaceuticals SA, H1 2015
Rheumatoid Arthritis - Pipeline by Richter Gedeon Nyrt., H1 2015
Rheumatoid Arthritis - Pipeline by Rottapharm SpA, H1 2015
Rheumatoid Arthritis - Pipeline by Salix Pharmaceuticals Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Sandoz International GmbH, H1 2015
Rheumatoid Arthritis - Pipeline by Sareum Holdings Plc, H1 2015
Rheumatoid Arthritis - Pipeline by SBI Biotech Co., Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Selvita SA, H1 2015
Rheumatoid Arthritis - Pipeline by Shanghai Henlius Biotech Co., Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Shanghai Pharmaceutical Co., Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Spectrum Pharmaceuticals, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Sun Pharmaceutical Industries Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Swedish Orphan Biovitrum AB, H1 2015
Rheumatoid Arthritis - Pipeline by Synovo GmbH, H1 2015
Rheumatoid Arthritis - Pipeline by Syntrix Biosystems, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Takeda Pharmaceutical Company Limited, H1 2015
Rheumatoid Arthritis - Pipeline by TechnoPhage SA, H1 2015
Rheumatoid Arthritis - Pipeline by Teijin Pharma Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Teva Pharmaceutical Industries Limited, H1 2015
Rheumatoid Arthritis - Pipeline by TheraMAB, H1 2015
Rheumatoid Arthritis - Pipeline by Therapeutic Proteins International, LLC, H1 2015
Rheumatoid Arthritis - Pipeline by TiGenix NV, H1 2015
Rheumatoid Arthritis - Pipeline by Toleranzia AB, H1 2015
Rheumatoid Arthritis - Pipeline by Toyama Chemical Co., Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by TSH Biopharm Corporation Limited, H1 2015
Rheumatoid Arthritis - Pipeline by TxCell SA, H1 2015
Rheumatoid Arthritis - Pipeline by UCB S.A., H1 2015
Rheumatoid Arthritis - Pipeline by ugichem GmbH, H1 2015
Rheumatoid Arthritis - Pipeline by UNIZYME Laboratories A/S, H1 2015
Rheumatoid Arthritis - Pipeline by Vaccinex, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Vertex Pharmaceuticals Incorporated, H1 2015
Rheumatoid Arthritis - Pipeline by Vichem Chemie Research Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Vicore Pharma AB, H1 2015
Rheumatoid Arthritis - Pipeline by Vida Therapeutics Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Vivia Biotech, S.L., H1 2015
Rheumatoid Arthritis - Pipeline by XBiotech USA, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Xencor, Inc., H1 2015
Rheumatoid Arthritis - Pipeline by Xenexus Pharmaceuticals Pty. Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by XTL Biopharmaceuticals Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Yuhan Corporation, H1 2015
Rheumatoid Arthritis - Pipeline by Yungjin Pharm Ind. Co., Ltd., H1 2015
Rheumatoid Arthritis - Pipeline by Zydus Cadila Healthcare Limited, H1 2015
Rheumatoid Arthritis - Pipeline by Zynerba Pharmaceuticals, Inc., H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Rheumatoid Arthritis Therapeutics - Recent Pipeline Updates, H1 2015
Rheumatoid Arthritis - Dormant Projects, H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..1), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..2), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..3), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..4), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..5), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..6), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..7), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..8), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..9), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..10), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..11), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..12), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..13), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..14), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..15), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..16), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..17), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..18), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..19), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..20), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..21), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..22), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..23), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..24), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..25), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..26), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..27), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..28), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..29), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..30), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..31), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..32), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..33), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..34), H1 2015
Rheumatoid Arthritis - Dormant Projects (Contd..35), H1 2015
Rheumatoid Arthritis - Discontinued Products, H1 2015
Rheumatoid Arthritis - Discontinued Products (Contd..1), H1 2015
Rheumatoid Arthritis - Discontinued Products (Contd..2), H1 2015
Rheumatoid Arthritis - Discontinued Products (Contd..3), H1 2015
Rheumatoid Arthritis - Discontinued Products (Contd..4), H1 2015
Rheumatoid Arthritis - Discontinued Products (Contd..5), H1 2015
Rheumatoid Arthritis - Discontinued Products (Contd..6), H1 2015
Rheumatoid Arthritis - Discontinued Products (Contd..7), H1 2015
Rheumatoid Arthritis - Discontinued Products (Contd..8), H1 2015
Rheumatoid Arthritis - Discontinued Products (Contd..9), H1 2015
Rheumatoid Arthritis - Discontinued Products (Contd..10), H1 2015
List of Figures
Number of Products under Development for Rheumatoid Arthritis, H1 2015
Number of Products under Development for Rheumatoid Arthritis - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report